DARE
Dare Bioscience IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$35.50M
P/E Ratio
—
EPS
$-0.91
Beta
1.09
52W High
$3.78
52W Low
$1.27
50-Day MA
$2.11
200-Day MA
$1.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.27
PEG Ratio
0.00
About Dare Bioscience Inc
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $1.16M |
| Gross Profit (TTM) | 619,100 |
| EBITDA | $-9.96M |
| Operating Margin | -1967.00% |
| Return on Equity | -2543.00% |
| Return on Assets | -32.20% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $0.05 |
| Price-to-Book | 48.38 |
| Price-to-Sales (TTM) | 30.68 |
| EV/Revenue | 16.07 |
| EV/EBITDA | -2.06 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 499.60% |
| Shares Outstanding | $14.98M |
| Float | $13.70M |
| % Insiders | 8.08% |
| % Institutions | 8.39% |
Historical Volatility
HV 10-Day
65.36%
HV 20-Day
86.78%
HV 30-Day
73.05%
HV 60-Day
58.09%
HV Rank
73.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($9.67 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026